COMMUNIQUÉS West-GlobeNewswire

Nabriva Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
29/05/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., May 29, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
Antares Pharma to Present at the Jefferies 2018 Healthcare Conference
29/05/2018
EWING, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS ) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies 2018 Healthcare Conference on [...]
Axsome Therapeutics to Present Data on AXS-05 at the 2018 American Society of Clinical Psychopharmacology Annual Meeting
29/05/2018
NEW YORK, May 29, 2018 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM ), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Neuralstem to Participate at the BIO 2018 International Convention
29/05/2018
GERMANTOWN, Md., May 29, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq: CUR ), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that Karl Johe, PhD, Chief [...]
Akcea Therapeutics to Present at the Jefferies Global Healthcare Conference
29/05/2018
CAMBRIDGE, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc.(NASDAQ: AKCA ), an affiliate of Ionis Pharmaceuticals, Inc., today announced that management will present a company overview at the Jefferies [...]
Aileron Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
29/05/2018
CAMBRIDGE, Mass., May 29, 2018 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN ), the leader in the field of stapled peptide therapeutics for cancers and other diseases, today announced that Manuel Aivado, CMO [...]
Milestone Scientific Announces Two Additional Independent Distributors in the U.S. for CompuFlo® Epidural System
29/05/2018
Agreements cover territories within the Northwest and Mid-Atlantic Regions LIVINGSTON, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Milestone Scientific Inc . (NYSE: MLSS ), a leading developer of computerized drug delivery [...]
AxoGen, Inc. Announces Repayment in Full of its $25 million Outstanding Debt
29/05/2018
ALACHUA, Fla., May 29, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ: AXGN ), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, announced that it repaid in full its [...]
Amunix announces report by Bioverativ on unprecedented half-life obtained in patients treated with a novel, long-acting FVIII utilizing Amunix’s XTEN® technology
29/05/2018
MOUNTAIN VIEW, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- Amunix Operating Inc. is pleased to report that Bioverativ (a Sanofi company) has announced preliminary Phase 1/2a safety and pharmacokinetic clinical data for [...]
Axovant Strengthens Management Team and Completes Organizational Restructuring in Preparation for Pipeline Expansion
29/05/2018
Gavin Corcoran, current Chief Medical Officer of Allergan plc, to join Axovant as EVP of R&D Michael Hayden, former Chief Scientific Officer and President of Global R&D at Teva, to serve as Chairman of Axovant’s [...]
Rhizen Pharmaceuticals S.A. Announces Presentations on Tenalisib (RP6530) at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
29/05/2018
La Chaux-de-Fonds, Switzerland, May 29, 2018 (GLOBE NEWSWIRE) -- Rhizen Pharmaceuticals S.A., a clinical-stage biotechnology company developing Tenalisib (RP6530), a highly selective and orally active dual PI3K delta/ [...]
T2 Biosystems Receives FDA Clearance to Market T2Bacteria Panel for Detection of Sepsis-Causing Pathogens
29/05/2018
First FDA-cleared test to identify sepsis-causing bacteria direct from whole blood Cuts time to diagnosis from days to hours, allowing greater certainty and new protocols for deadly infections in hospital setting [...]
Akers Biosciences Withdraws FDA 510(k) Submission for PIFA Chlamydia Rapid Assay Pending Further Evaluation
29/05/2018
THOROFARE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that, upon a [...]
Akers Biosciences Announces a Change to the Board of Directors
29/05/2018
THOROFARE, N.J., May 29, 2018 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that Raymond F. [...]
Evogene Reports First Quarter 2018 Financial Results
29/05/2018
Conference call and webcast, today at 9:00 am Eastern Time REHOVOT, Israel, May 29, 2018 (GLOBE NEWSWIRE) -- Evogene Ltd. (NASDAQ: EVGN ) (TASE: EVGN ), a leading biotechnology company developing novel products for life [...]
FDA Accepts Larotrectinib New Drug Application and Grants Priority Review
29/05/2018
– PDUFA date set for November 26, 2018 – STAMFORD, Conn., May 29, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq: LOXO ), a biopharmaceutical company innovating the development of highly selective medicines for [...]
BriaCell Publishes Clinical Findings in 2018 American Society of Clinical Oncology (ASCO) Meeting
29/05/2018
BERKELEY, Calif. and VANCOUVER, British Columbia, May 29, 2018 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell") (TSX-V: BCT ) (OTCQB:BCTXF), an immuno-oncology focused biotechnology company with a [...]
TRU NIAGEN® to be featured at the American Society for Nutrition's Annual Meeting
29/05/2018
ChromaDex Chief Scientific Advisor, Charles Brenner, PhD, to discuss nicotinamide riboside in educational session IRVINE, Calif., May 29, 2018 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ: CDXC ), an integrated, science- [...]
Solon Eiendom ASA : Primary insider notification
29/05/2018
(Oslo, Norway, May 29, 2018) UFI AS has today bought 158 554 shares in Solon Eiendom ASA at a price of NOK 30.00 per share. Solon Eiendom ASA Board Member Øystein A. Landvik owns 33,34 % of the shares in UFI AS. [...]

Pages